TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 1 | 4 | 6 | 21 | 50 | 110 | 138 | 55 |
| P | %wins | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/18/22 11:39 | 2/17/22 | HSKA | Heska Corp | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Sveen David E. | CO | D | M.d | 283 | 33.06 | 0 | 9 | 26 | 42 | D | |||||||||||||||
5/18/15 19:00 | 5/15/15 | HSKA | Heska Corp | DE | Health | BioPrd | Biological Products, (No Diag | Sveen David E. | CO | D | M.d | 74 | 10.19 | 2 | 7 | 34 | 29 | D | 276 | 171 | 82 | 39 | 12 | 0 | 4 | -1 | 1 | 7 | 7 | 21 | 24 | 37 | |
12/2/14 15:51 | 11/30/14 | HSKA | Heska Corp | DE | Health | BioPrd | Biological Products, (No Diag | Sveen David E. | CO | D | P | 300 | 14.00 | 1 | 21 | New | 21 | I | 71 | 91 | 42 | 10 | 21 | -9 | -3 | -3 | 4 | 6 | 21 | 50 | 110 | 138 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |